no code implementations • 19 Dec 2023 • Geoffrey van Dover, Josh Javor, Jourdan Ewoldt, Ha Eun Lee, Mikhail Zhernenkov, Guillaume Freychet, Patryk Wasik, Dana Brown, David Bishop, Christopher Chen
Understanding the structural and functional development of human-induced pluripotent stem-cell-derived cardiomyocytes is essential to engineering cardiac tissue that enables pharmaceutical testing, modeling diseases, and designing therapies.
